Assessment of occurrence of metabolic syndrome among post-menopausal women


  • Bharath G. Department of Medicine Koppal Institute of Medical Science, Koppal, Karnataka, India
  • Avinash Itagi Department of Medicine, KIMS Hubbali, Karnataka, India
  • Mahendra S. V. Department of Medicine Koppal Institute of Medical Science, Koppal, Karnataka, India



Components of metabolic syndrome, Metabolic syndrome, Postmenopausal women, Waist circumference


Background: Metabolic syndrome is described by the clustering of several risk factors for cardiovascular disease such as hypertension, dyslipidemia, obesity, Insulin resistance, and high fasting plasma glucose. Objective of this study was to determine the frequency and evaluate the components of metabolic syndrome in post-menopausal women.

Methods: This Descriptive study was conducted in OPD as well as IPD of Department of Medicine, Sri Siddhartha Medical college Hospital and Research Centre, Tumkur After obtaining written informed consent. Period of study was 24 months.  Purposive sampling was used.

Results: Mean age of post-menopausal women was 54.19±8.454 years. Mean age of menopause was 45.41±2.428.  Majority of patients between were between 45-50 years (33.7%). There were high number of women (34.6%) whose postmenopausal duration ranged between 6-10 years. In our study 10(9.6%) postmenopausal women had type 2 DM and 15(14.4%) postmenopausal women had HTN. Metabolic syndrome was present in 65(62.5%) postmenopausal women and absent in 39(37.5%) postmenopausal women. Waist circumference >80 cm (68.3) was the most prevalent component of metabolic syndrome followed by HDL <50 mg/dl (53.8%), BP>130/80 mmHg (51%) triglycerides >150 mg/dl (44.2%)/ and FBS>100 mg/dl (39.4%). There was statistical significance observed between the components of metabolic syndrome and metabolic syndrome in postmenopausal women.

Conclusions: The prevalence of metabolic syndrome was high in our study. The components of metabolic syndrome such as waist circumference, FBS, blood pressure, triglycerides were significantly raised and HDL levels were significantly reduced in post-menopausal women with metabolic syndrome.


Cleeman J. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J Am Med Asso. 2001;285(19):2486-97.

Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res. 2002;57:257-75.

Petri Nahas EA, Padoani NP, Nahas-Neto J, Orsatti FL, Tardivo AP. Dias R. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climacteric J Int Menopause Soc. 2009 Oct;12(5):431-8.

S López-López R, Huerta R, Malacara JM. Age at menopause in women with type 2 diabetes mellitus. Menopause N Y N. 1999;6(2):174-8.

Al-Azzawi F. The menopause and its treatment in perspective. Postgrad Med J. 2001 May:77(907):292-304.

Mesch VR, Boero LE, Siscles NO, Royer M, Prada M, Sayegh E, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric. 2006;9(1):40-8.

Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med. 1995;155(1):57-61.

Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988. 1994. Arch Int Med. 2003;163(4):427-36.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005:112:2735-52.

Galassi A, Reynolds K, He J. Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis. Am J Med. 2006;119:812-9.

Pandey S, Srinivas M, Agashe S, Joshi J, Galvankar P. Prakasam CP et al Menopause and metabolic syndrome: A study of 498 urban women from western India. J Midlife Health. 2010 Jul-Dec;1(2):63-9.

Sharma S, Aggarwal N, Joshi B, Suri V, Badada S. Prevalence of metabolic G syndrome in pre- and postmenopausal women: A prospective study from apex institute of North India. J Mid-life Health. 2016;7:169-74.

Heldari R, Sadeghi M, Talaei M, Rabiei K, Mohammudifard N, Sarrafzadegan N. Metabolic syndrome in menopausal transition: Isfahan Healthy Heart Program, a population-based study. Diabetol Metab Syndr. 2010;2:59.

Jayasheela K, Ebenezer D, Vaibhav L, Thomas V, Bijesh Y. Kekre A. Prevalence of metabolic syndrome among postmenopausal women in South India. Int J Reprod. 2018;7:2364-70.

Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP. Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obes. 2006;30(1):106-11.

Sapkota AS, Sapkota A. Acharya K, Raut M, Jha B. Study of metabolic syndrome in postmenopausal women. Ann Clin Chem Lab Med. 2015;1(1):6-11.

Jouyandeh Z, Nayebzadeh F, Qorbani M, Asadi M. Metabolic syndrome and menopause. J Diab Metab Disorders. 2013:12:1.

Marjani A, Moghasemi S. Metabolic Sydrome among Potmenopausal women in gorgan. Int J Endocrinenol. 2012;2012:953627.

Jesmin S, Islam AS, Akter S, Islam MM, Sultan SN, Yamaguchi N et al. Metabolic syndrome among pre- and post-menopausal rural women in Bangladesh: result from a population-based study. BMC Res Notes. 2013 Dec;6(1):157.

Kim HM, Park J. Ryu SY, Kim J. The Effect of Menopause on the Metabolic Syndrome Among Korean Women: The Korean National Health and Nutrition Examination Survey, 2001. Diabetes Care. 2007 Mar 1:30(3):701.






Original Research Articles